Lemonade, Inc.
NYSELMND enters the back half of August carrying a bruising month — down 25% — while short sellers quietly reduce their exposure and analysts scramble to reset expectations after a punishing earnings reaction. The most striking tension this week is the gap between what shorts are doing and what the stock has already done. Short interest has edged lower to 13.9% of free float, down…
Snapshot as of 4 Oct 2026
LMND enters the back half of August carrying a bruising month — down 25% — while short sellers quietly reduce their exposure and analysts scramble to reset expectations after a punishing earnings reaction. The most…
Lemonade is down nearly 10% on the week to $70.14, yet its short sellers are adding positions and its CFO just sold $5.8 million of stock — a combination that sharpens the stakes ahead of the July 29 earnings…
Lemonade heads into its July 29 earnings with a sharp analyst downgrade landing on the same day the stock trades 50% above where it was just one month ago. The most significant development this week is Morgan Stanley's…
LMND heads into the week with a contradictory setup: short sellers are quietly covering while options traders have shifted to their most bullish posture in months — yet the stock is still down 8% on the week and…
LMND heads into its Q1 2026 earnings release with short sellers notably reducing pressure — yet a 14.5% short interest figure still looms large over the name. The borrow market tells a story of easing conviction among…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LMND — free to start on ORTEX.
Sign up for free →Open LMND on ORTEX